EQUINE INFECTIOUS-ANEMIA VIRUS (EIAV) - HUMORAL RESPONSES OF RECIPIENT PONIES AND ANTIGENIC VARIATION DURING PERSISTENT INFECTION

被引:59
作者
RWAMBO, PM
ISSEL, CJ
ADAMS, WV
HUSSAIN, KA
MILLER, M
MONTELARO, RC
机构
[1] LOUISIANA STATE UNIV,LOUISIANA AGR EXPT STN,CTR AGR,DEPT VET SCI,BATON ROUGE,LA 70803
[2] LOUISIANA STATE UNIV,LOUISIANA AGR EXPT STN,DEPT MICROBIOL,BATON ROUGE,LA 70803
[3] LOUISIANA STATE UNIV,LOUISIANA AGR EXPT STN,DEPT BIOCHEM,BATON ROUGE,LA 70803
[4] LOUISIANA STATE UNIV,SCH VET MED,DEPT VET MICROBIOL & PARASITOL,BATON ROUGE,LA 70803
关键词
D O I
10.1007/BF01311054
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Three ponies were inoculated with plasma containing 104.8 TCID50 of equine infectious anemia virus (EIAV) and observed for 165 to 440 days. Each pony developed a febrile response within 3 weeks of infection during which a plasma viremia ≥103.5 TCID50/ml was observed. Analyses of four isolates from sequential febrile episodes in a single pony were conducted by two-dimensional tryptic peptide maps and with monoclonal antibodies in immunoblots. Structural and antigenic alterations were observed in the envelope glycoproteins gp90 and gp45, with greatest variation in gp90. Specific IgG to EIAV gp90, gp45, and p26 of homologous and heterologous isolates was detectable by immunoblots within one month after infection although IgG levels to gp45 at this time were relatively low. The group-specific determinants of gp90 and gp45 were more antigenic than those of p26; however, binding of IgG to these determinants did not correlate with neutralization of EIAV as assayed in fetal equine kidney cells. Neutralizing antibodies were first detectable within two months of infection and only neutralized viruses isolated prior to serum collection. Neutralizing activity of sera collected later in the infection was broadly reactive regardless of the number of clinical episodes the donor had suffered. © 1990 Springer-Verlag.
引用
收藏
页码:199 / 212
页数:14
相关论文
共 34 条
[1]  
AMBORSKI GF, 1979, AM J VET RES, V40, P302
[2]  
BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
[3]  
CHEEVERS WP, 1985, REV INFECT DIS, V7, P83
[4]   GENOMIC CHANGES ASSOCIATED WITH ANTIGENIC VARIATION OF VISNA VIRUS DURING PERSISTENT INFECTION [J].
CLEMENTS, JE ;
PEDERSEN, FS ;
NARAYAN, O ;
HASELTINE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (08) :4454-4458
[5]  
ELDER JH, 1977, J BIOL CHEM, V252, P6510
[6]   BIOCHEMICAL EVIDENCE THAT MCF MURINE LEUKEMIA VIRUSES ARE ENVELOPE (ENV) GENE RECOMBINANTS [J].
ELDER, JH ;
GAUTSCH, JW ;
JENSEN, FC ;
LERNER, RA ;
HARTLEY, JW ;
ROWE, WP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (10) :4676-4680
[7]   SEQUENCE HOMOLOGY AND MORPHOLOGIC SIMILARITY OF HTLV-III AND VISNA VIRUS, A PATHOGENIC LENTI-VIRUS [J].
GONDA, MA ;
WONGSTAAL, F ;
GALLO, RC ;
CLEMENTS, JE ;
NARAYAN, O ;
GILDEN, RV .
SCIENCE, 1985, 227 (4683) :173-177
[8]   GENOMIC DIVERSITY OF THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME VIRUS HTLV-III - DIFFERENT VIRUSES EXHIBIT GREATEST DIVERGENCE IN THEIR ENVELOPE GENES [J].
HAHN, BH ;
GONDA, MA ;
SHAW, GM ;
POPOVIC, M ;
HOXIE, JA ;
GALLO, RC ;
WONGSTAAL, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (14) :4813-4817
[9]   GENETIC-VARIATION IN HTLV-III/LAV OVER TIME IN PATIENTS WITH AIDS OR AT RISK FOR AIDS [J].
HAHN, BH ;
SHAW, GM ;
TAYLOR, ME ;
REDFIELD, RR ;
MARKHAM, PD ;
SALAHUDDIN, SZ ;
WONGSTAAL, F ;
GALLO, RC ;
PARKS, ES ;
PARKS, WP .
SCIENCE, 1986, 232 (4757) :1548-1553
[10]   ANTIGENIC ANALYSIS OF EQUINE INFECTIOUS-ANEMIA VIRUS (EIAV) VARIANTS BY USING MONOCLONAL-ANTIBODIES - EPITOPES OF GLYCOPROTEIN GP90 OF EIAV STIMULATE NEUTRALIZING ANTIBODIES [J].
HUSSAIN, KA ;
ISSEL, CJ ;
SCHNORR, KL ;
RWAMBO, PM ;
MONTELARO, RC .
JOURNAL OF VIROLOGY, 1987, 61 (10) :2956-2961